IPREG-MP - Medroxyprogesterone Acetate + Sustained Release 30mg | Intralife Pharmaceuticals
GYNAEBULL
Premium

IPREG-MP

MRP: 1,890

Packaging: 10x10

Pack Type: tablet

Composition:

Medroxyprogesterone Acetate + Sustained Release 30mg

Indication:

Secondary Amenorrhea, Abnormal Uterine Bleeding, Endometrial Hyperplasia

Description:

Medroxyprogesterone Acetate Sustained Release 30 mg Tablet is a synthetic progestin used in the treatment of various menstrual and hormonal disorders. It mimics the actions of the natural hormone progesterone, helping regulate ovulation and menstrual cycles. The sustained release formulation ensures a gradual and consistent release of the active ingredient, providing long-lasting therapeutic effects with once-daily dosing. It is commonly prescribed for conditions such as secondary amenorrhea, abnormal uterine bleeding, endometriosis, and as part of hormone replacement therapy (HRT).

Tags:

Hormonal Therapy Women's Health Menstrual Disorders Prescription Required Sustained Release Tablets Progesterone-Based Endometriosis Management
  • Regulates menstrual cycles in women with secondary amenorrhea
  • Manages abnormal uterine bleeding due to hormonal imbalance
  • Supports treatment of endometriosis symptoms
  • Helps maintain hormone levels during hormone replacement therapy
  • Convenient once-daily sustained release formulation

Usage Information

Dosage

Usual Adult Dose: One tablet daily or as directed by the physician Take the tablet at the same time each day, with or without food Swallow whole; do not crush or chew Follow the full course as prescribed even if symptoms improve early Always consult your gynecologist or endocrinologist for appropriate dosing

Side Effects

Headache Nausea Breast tenderness Mood changes or irritability Weight gain Menstrual irregularities Bloating or abdominal discomfort Seek medical attention if you experience: Vision changes Severe headaches Chest pain or shortness of breath Signs of blood clots (leg swelling or pain)

Contraindications

Known or suspected pregnancy Undiagnosed vaginal bleeding History of thromboembolic disorders (e.g., DVT, PE) Liver dysfunction or liver disease Known hormone-sensitive cancers (e.g., breast or endometrial cancer) Hypersensitivity to medroxyprogesterone or any excipient in the formulation

Availability

medroxyprogesterone acetate sr 30mg, hormonal imbalance treatment, progesterone therapy tablets, menstrual disorder medicine, medroxyprogesterone sustained release, progestin tablets, hormone replacement tablets, abnormal bleeding treatment, endometriosis medication, progesterone supplement tablets

Medroxyprogesterone Acetate SR 30mg Tablet – Hormonal Therapy | Intralife Pharmaceuticals | Intralife